Oleg Gluz, Ulrike A. Nitz, Matthias Christgen, Sherko Kuemmel, Johannes Holtschmidt, Johannes Schumacher, Philip Raeth, Andreas D. Hartkopf, Kerstin Luedtke-Heckenkamp, Marianne Just, Raquel von Schumann, Silke Polata, Timo Schinkoethe, Monika K. Graeser, Ronald Kates, Rachel Wuerstlein, Nadia Harbeck. "Survival Analysis of the WSG TP-II Trial: Neoadjuvant Trastuzumab and Pertuzumab Plus Endocrine Therapy Versus Chemotherapy in Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Positive Early Breast Cancer." Journal of Clinical Oncology, 2026. doi:10.1200/jco-25-01047